PRESS RELEASES

Date	Title
May 18, 2020	Ardelyx Strengthens Management Team with Appointment of Susan Rodriguez as Chief Commercial Officer
May 7, 2020	Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights
Mar 16, 2020	Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors
Mar 6, 2020	Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights
Feb 26, 2020	Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference
Feb 19, 2020	Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Dec 4, 2019	Ardelyx Announces Pricing of Upsized Public Offering of Common Stock
Dec 4, 2019	Ardelyx Announces Proposed Public Offering of Common Stock
Dec 3, 2019	Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialysis
Dec 2, 2019	Ardelyx to Host Conference Call on December 3 to Review Results from the Pivotal Phase 3 PHREEDOM Study

FAQs

Email Alerts

Connect

Bay Area
34175 Ardenwood Boulevard
Fremont, CA 94555

Boston Area
200 West Street, 4th Floor
Waltham, MA 02451

Phone: 510.745.1700

Inquiries:
General: info@ardelyx.com
Media: media@ardelyx.com
Investor: investor@ardelyx.com
Business Development: partnering@ardelyx.com